Krane Shares Trust. Holdings as of Jun 30, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Invesco Government & Agency PortfolioCash or money market | 3.55% | $2.53M | 2,526,804 |
| Legend Biotech CorpLEGN | 1.28% | $909.37K | 31,488 |
| BeOne Medicines AG | 8.84% | $803.31K | 289,918 |
| INNOVENT BIOLOGICS, INC. | 8.80% | $799.27K | 617,500 |
| WUXI BIOLOGICS (CAYMAN) INC. | 7.51% | $682.26K | 1,212,635 |
| WuXi AppTec Co., Ltd. | 5.79% | $607.24K | 224,720 |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 4.59% | $481.59K | 426,408 |
| Shenzhen Mindray Bio-Medical Electronics Co Ltd | 4.27% | $448.54K | 152,155 |
| Akeso Inc | 3.72% | $337.90K | 236,000 |
| CSPC PHARMACEUTICAL GROUP LIMITED | 3.68% | $334.22K | 2,948,889 |
| SINO BIOPHARMACEUTICAL LIMITED | 3.39% | $307.47K | 4,287,750 |
| WuXi AppTec Co., Ltd. | 3.35% | $304.37K | 121,784 |
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | 2.85% | $259.12K | 538,000 |
| YUNNAN BAIYAO GROUP CO., LTD | 2.30% | $241.82K | 235,223 |
| Shanghai United Imaging Healthcare Co., Ltd. | 2.27% | $238.39K | 108,508 |
| 3SBio Inc. | 2.49% | $225.89K | 822,500 |
| Aier Eye Hospital Group Co., Ltd. | 2.10% | $220.13K | 1,227,963 |
| Sichuan Biokin Pharmaceutical Co Ltd | 1.97% | $206.26K | 32,322 |
| ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD. | 1.73% | $181.99K | 76,734 |
| Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | 1.85% | $168.10K | 23,700 |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 1.55% | $162.20K | 194,015 |
| Haisco Pharmaceutical Group Co., Ltd. | 1.53% | $160.10K | 111,200 |
| SINOPHARM GROUP CO. LTD. | 1.67% | $151.81K | 586,800 |
| HUADONG MEDICINE CO., LTD | 1.36% | $142.77K | 233,941 |
| Shanghai Allist Pharmaceuticals Co Ltd | 1.34% | $140.60K | 59,328 |
| RemeGen Co Ltd | 1.26% | $132.07K | 46,717 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 1.24% | $129.98K | 266,529 |
| WuXi XDC Cayman Inc | 1.35% | $122.92K | 132,500 |
| Pharmaron Beijing Co., Ltd. | 1.15% | $120.47K | 191,875 |
| Shanghai Pharmaceuticals Holding Co., Ltd. | 1.13% | $118.92K | 355,812 |
| China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. | 1.03% | $107.73K | 220,711 |
| Genscript Biotech Corp | 1.11% | $101.03K | 508,000 |
| SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. | 0.94% | $98.46K | 142,265 |
| RemeGen Co Ltd | 1.05% | $95.45K | 79,000 |
| Shenzhen New Industries Biomedical Engineering Co Ltd | 0.90% | $94.71K | 103,900 |
| BEIJING TONG REN TANG CO., LTD | 0.86% | $90.53K | 180,490 |
| XtalPi Holdings Limited | 1.00% | $90.44K | 727,000 |
| Shanghai RAAS Blood Products Co., Ltd. | 0.79% | $82.52K | 876,134 |
| Chongqing Zhifei Biological Products Co., Ltd. | 0.76% | $80.04K | 315,472 |
| CSPC Innovation Pharmaceutical Co Ltd | 0.74% | $77.86K | 131,757 |
| CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | 0.74% | $77.63K | 53,708 |
| Imeik Technology Development Co Ltd | 0.72% | $75.40K | 39,840 |
| APT Medical Inc | 0.70% | $73.29K | 18,599 |
| Beijing Wantai Biological Pharmacy Enterprise Co Ltd | 0.67% | $70.50K | 120,442 |
| Hebei Changshan Biochemical Pharmaceutical Co Ltd | 0.56% | $59.21K | 116,500 |
| Hangzhou Tigermed Consulting Co., Ltd | 0.46% | $47.76K | 45,850 |
| ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD. | 0.08% | $8.06K | 3,400 |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 0.07% | $7.19K | 8,600 |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 0.06% | $6.63K | 13,600 |
| Shanghai Pharmaceuticals Holding Co., Ltd. | 0.04% | $3.74K | 11,200 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.